Cargando…
Myoclonus dystonia and muscular dystrophy: ɛ‐sarcoglycan is part of the dystrophin‐associated protein complex in brain
BACKGROUND: Myoclonus‐dystonia is a neurogenic movement disorder caused by mutations in the gene encoding ɛ‐sarcoglycan. By contrast, mutations in the α‐, β‐, γ‐, and δ‐sarcoglycan genes cause limb girdle muscular dystrophies. The sarcoglycans are part of the dystrophin‐associated protein complex in...
Autores principales: | Waite, Adrian J., Carlisle, Francesca A., Chan, Yiumo Michael, Blake, Derek J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129563/ https://www.ncbi.nlm.nih.gov/pubmed/27535350 http://dx.doi.org/10.1002/mds.26738 |
Ejemplares similares
-
A Genetics Pearl for Counseling Patients with Epsilon-Sarcoglycan Myoclonus-Dystonia
por: Higinbotham, Alissa S., et al.
Publicado: (2023) -
Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice
por: Duclos, Franck, et al.
Publicado: (1998) -
Sarcoglycan Complex: IMPLICATIONS FOR METABOLIC DEFECTS IN MUSCULAR DYSTROPHIES
por: Groh, Séverine, et al.
Publicado: (2009) -
δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches
por: Blain, Alison M, et al.
Publicado: (2011) -
Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy
por: Alonso-Pérez, Jorge, et al.
Publicado: (2021)